Programmed cell death-1 ligand (PD-L1) expression on circulating CD45(-) cells is an independent prognostic factor for overall survival in patients (Pts) with lung cancer in a prospective, multicenter cohort.

Daniel J. Boffa,Jorge Nieva,Lyudmila Bazhenova,Rachel Krupa,David Lu,Ryon Graf,Jessica Louw,Lyndsey Dugan,Adam Jendrisak,Michelle C. Salazar,Samir S. Makani,Marisa Magaña,Sarah Orr,Kelly Bethel,Yipeng Wang,Dena Marrinucci,Ryan Dittamore

Programmed cell death-1 ligand (PD-L1) expression on circulating CD45(-) cells is an independent prognostic factor for overall survival in patients (Pts) with lung cancer in a prospective, multicenter cohort.

2016

Daniel J. Boffa
Jorge Nieva
Lyudmila Bazhenova
Rachel Krupa
David Lu
Ryon Graf
Jessica Louw
Lyndsey Dugan
Adam Jendrisak
Michelle C. Salazar
Samir S. Makani
Marisa Magaña
Sarah Orr
Kelly Bethel
Yipeng Wang
Dena Marrinucci
Ryan Dittamore

8524Background: Lung cancer pts currently require biopsies to diagnose and profile tumors prior to treatment. There is a need for tumor profiling from circulating biomarkers to avoid invasive proce...

Keywords:

Cohort
PD-L1
Pathology
Lung cancer
Cancer research
Programmed cell death 1
Medicine
circulating biomarkers
pd l1 expression
Oncology
in patient
overall survival
prognostic factor
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations